Isis Pharmaceuticals
(NASDAQ: ISIS)
22.58
-0.50
-2.17%
-0.50
-2.17%
MORE ON ISIS
| 2013 Q1 | 2012 Q4 | 2012 Q3 | 2012 Q2 | 2012 Q1 | |
| Period End Date | 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | 03/31/2012 |
| Stmt Source | N/A | N/A | N/A | N/A | 10-Q |
| Stmt Source Date | 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | 05/07/2013 |
| Stmt Update Type | Original | Original | Original | Original | Updated |
| Currency Code | USD | USD | USD | USD | USD |
| Assets | |||||
Cash, Equiv and Short Term Investments
|
416.8 | 374.4 | 343.6 | 336.0 | 333.9 |
| Cash and Cash Equivalents | 107.7 | 124.5 | 84.6 | 85.6 | 56.4 |
| Short Term Investments | 309.1 | 250.0 | 259.0 | 250.4 | 277.6 |
|
Receivables
|
1.2 | 0.5 | 3.5 | 1.6 | 1.4 |
| Accounts Receivable | 1.2 | 0.5 | 3.5 | 1.6 | 1.4 |
| Inventories | 5.8 | 6.1 | 6.7 | 7.1 | 4.9 |
| Other Current Assets | 8.1 | 42.3 | 7.8 | 5.7 | 7.4 |
| Total Current Assets | 431.8 | 423.4 | 361.6 | 350.4 | 347.6 |
|
Net Property,Plant,and Equipment
|
89.7 | 91.1 | 92.6 | 94.0 | 95.1 |
|
Gross Property,Plant,and Equipment
|
0.0 | 145.5 | 0.0 | 0.0 | 0.0 |
| Land and Improvements | 0.0 | 13.0 | 0.0 | 0.0 | 0.0 |
| Buildings and Improvements | 0.0 | 48.1 | 0.0 | 0.0 | 0.0 |
| Machinery,Furniture/Equipment | 0.0 | 49.5 | 0.0 | 0.0 | 0.0 |
| Leasehold and Improvements | 0.0 | 34.9 | 0.0 | 0.0 | 0.0 |
| Accumulated Depreciation | 0.0 | -54.5 | 0.0 | 0.0 | 0.0 |
|
Goodwill and Other Intangible Assets
|
25.6 | 18.6 | 18.2 | 17.7 | 17.1 |
| Other Intangible Assets | 25.6 | 18.6 | 18.2 | 17.7 | 17.1 |
| Investments and Advances | 5.8 | 0.0 | 5.6 | 5.6 | 5.4 |
| Other Non-Current Assets | 0.0 | 12.5 | 7.8 | 4.7 | 5.6 |
| Total Non-Current Assets | 121.1 | 122.2 | 124.1 | 122.0 | 123.2 |
| Total Assets | 553.0 | 545.7 | 485.7 | 472.4 | 470.8 |
| Liabilities and Shareholders' Equity | |||||
|
Payables
|
9.0 | 10.2 | 5.3 | 6.2 | 5.3 |
| Accounts Payable | 5.4 | 10.2 | 5.3 | 6.2 | 5.3 |
| Taxes Payable | 3.6 | 0.0 | 0.0 | 0.0 | 0.0 |
| Accrued Expenses,Current | 21.6 | 23.3 | 17.7 | 20.6 | 19.1 |
| Current Debt | 4.5 | 4.9 | 5.2 | 5.3 | 2.9 |
|
Deferred Liabilities,Current
|
35.2 | 35.9 | 23.4 | 23.0 | 34.3 |
| Deferred Revenue,Current | 35.2 | 35.9 | 23.4 | 23.0 | 34.3 |
| Total Current Liabilities | 70.3 | 74.3 | 51.6 | 55.1 | 61.7 |
|
LT Debt and Capital Lease Obligation
|
222.8 | 78.0 | 221.3 | 225.7 | 217.4 |
| Long Term Debt | 222.8 | 78.0 | 221.3 | 225.7 | 217.4 |
|
Deferred Liabilities, Non current
|
58.8 | 66.7 | 37.0 | 31.7 | 35.5 |
| Deferred Revenues,Non-Current | 58.8 | 66.7 | 37.0 | 31.7 | 35.5 |
| Other Non-Current Liabilities | 0.0 | 144.0 | 5.6 | 5.6 | 5.4 |
| Total Non-Current Liabilities and MI | 281.6 | 288.6 | 263.8 | 263.0 | 258.2 |
| Total Liabilities | 351.9 | 362.9 | 315.4 | 318.1 | 319.9 |
|
Capital Stock
|
0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Retained Earnings | -908.6 | -907.0 | -904.3 | -866.7 | -865.5 |
| Additional Paid in Capital | 1,091.8 | 1,077.2 | 1,073.7 | 1,019.9 | 1,016.5 |
| Accum Gains/ Losses Not Affecting RE | 17.8 | 12.5 | 0.8 | 1.0 | -0.2 |
| Total Equity | 201.1 | 182.8 | 170.3 | 154.3 | 150.9 |
| Total Liabilities and Equity | 553.0 | 545.7 | 485.7 | 472.4 | 470.8 |
| Ordinary Shares Outstanding | 102.70 | 101.48 | 101.19 | 100.32 | 100.18 |
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.